**Core Concept:** Buspirone is a selective serotonin-noradrenaline reuptake inhibitor (SSNRI) with partial agonist properties at 5-HT1A receptors. It is used to treat generalized anxiety disorder, social anxiety disorder, and panic disorder.

**Why the Correct Answer is Right:** Buspirone is a partial agonist at 5-HT1A autoreceptors, which results in a decrease in serotonin and noradrenaline reuptake. This leads to increased neurotransmitter levels in the synapse, promoting anxiolysis and sedation. Additionally, buspirone does not interact with other neurotransmitter systems, making it less likely to cause side effects associated with other antidepressants or anxiolytics.

**Why Each Wrong Option is Incorrect:**

A. Buspirone is not an SSRI (selective serotonin reuptake inhibitor) or SNRI (selective noradrenaline reuptake inhibitor). It has unique pharmacological properties.

B. Buspirone does not specifically target serotonin reuptake, unlike SSRIs.

C. Although buspirone has anxiolytic effects, its mechanism is different from benzodiazepines, which primarily act as positive allosteric modulators of GABA receptors.

D. Buspirone is not a MAOI (monoamine oxidase inhibitor), which can cause severe hypertensive crises when taken with certain foods rich in tyramine.

**Clinical Pearl:** Buspirone is a safer alternative to benzodiazepines for anxiolytic therapy, as it does not share their side effect profile and potential drug interactions. It is particularly useful for patients with respiratory compromise or those desiring a medication with fewer daytime sedation issues.

**Correct Answer:** C. Buspirone is used as an anxiolytic medication due to its unique pharmacological properties. It is essential to understand the different mechanisms of action for various psychiatric medications to select the appropriate therapy for patients appropriately.